E3 PreliminaryPreliminaryPEM not requiredObservationalPeer-reviewedReviewed
Standard · 3 min
Supervised selection of single nucleotide polymorphisms in chronic fatigue syndrome.
Cifuentes, Ricardo A, Barreto, Emiliano · Biomedica : revista del Instituto Nacional de Salud · 2011 · DOI
Quick Summary
This study examined whether specific genetic variations (single nucleotide polymorphisms or SNPs) could help predict who has ME/CFS. Researchers used a mathematical approach to identify the most useful genetic markers and found a combination of two genetic variants that correctly identified ME/CFS in about 73% of cases. When this genetic profile was combined with specific symptoms like muscle pain or sinus problems, the accuracy improved to over 87%.
Why It Matters
This research addresses the challenge of identifying objective biomarkers for ME/CFS diagnosis, which currently relies on clinical criteria alone. A validated genetic profile could eventually support diagnostic accuracy and potentially enable stratification of patients into biologically meaningful subgroups for treatment. However, this represents early methodological work requiring validation in independent populations.
Observed Findings
Supervised SNP selection achieved 72.8% prediction accuracy, superior to linkage disequilibrium-based selection (62.2%; p<0.01)
Two SNPs were identified in the optimal profile: NR3C1_11159943 major allele and 5HTT_7911132 minor allele
Muscular pain in the genetic risk stratum predicted ME/CFS with 87.1% accuracy versus 70.4% in the full dataset
Sinus nasal symptoms in the genetic risk stratum predicted ME/CFS with 92.5% accuracy versus 71.8% in the full dataset
Multiple algorithms produced similar accuracies with the SNP profile, suggesting stability across computational approaches
Inferred Conclusions
A supervised approach can identify a reliable SNP profile associated with ME/CFS that outperforms other selection methods
Combining genetic profiles with specific clinical symptoms substantially improves prediction accuracy
The identified SNP profile may define a biologically distinct subgroup of ME/CFS patients
Remaining Questions
Does this SNP profile predict ME/CFS in independent, prospective patient cohorts?
What are the biological mechanisms linking these genetic variants to ME/CFS pathophysiology?
What This Study Does Not Prove
This study does not establish that these genetic variants cause ME/CFS or determine the biological mechanisms underlying the disease. The high accuracy reported reflects findings in a single dataset and requires prospective validation in independent cohorts before clinical utility can be assessed. Predictive accuracy in retrospective analysis does not directly translate to diagnostic utility in clinical practice.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.